Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.
3.

A phase II trial of interferon alpha-2A, 5-fluorouracil, and cisplatin in patients with advanced esophageal carcinoma.

Ilson DH, Sirott M, Saltz L, Heelan R, Huang Y, Keresztes R, Kelsen DP.

Cancer. 1995 May 1;75(9):2197-202.

PMID:
7712428
4.

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.

Ilson DH, Ajani J, Bhalla K, Forastiere A, Huang Y, Patel P, Martin L, Donegan J, Pazdur R, Reed C, Kelsen DP.

J Clin Oncol. 1998 May;16(5):1826-34.

PMID:
9586897
5.

Sequential phase II trials of fluorouracil and interferon beta ser with or without sargramostim in patients with advanced colorectal carcinoma.

Wadler S, Haynes H, Rozenblit A, Hu X, Kaleya R, Wiernik PH.

Cancer J Sci Am. 1998 Sep-Oct;4(5):331-7.

PMID:
9815298
6.

A pilot trial of combination cisplatin, 5-fluorouracil and interferon-alpha in the treatment of advanced esophageal carcinoma.

Bazarbashi S, Rahal M, Raja MA, El Weshi A, Pai C, Ezzat A, Ajarim D, Memon M, Al Fadda M.

Chemotherapy. 2002 Sep;48(4):211-6.

PMID:
12218269
7.

Treatment of carcinoma of the esophagus with 5-fluorouracil and recombinant alfa-2a-interferon.

Wadler S, Fell S, Haynes H, Katz HJ, Rozenblit A, Kaleya R, Wiernik PH.

Cancer. 1993 Mar 1;71(5):1726-30.

PMID:
8448736
9.

Interferon alfa-2a and fluorouracil in the treatment of patients with advanced esophageal cancer.

Kelsen D, Lovett D, Wong J, Saltz L, Buckley M, Murray P, Heelan R, Lightdale C.

J Clin Oncol. 1992 Feb;10(2):269-74.

PMID:
1732428
10.

A phase I trial of concomitant chemoradiotherapy with cisplatin dose intensification and granulocyte-colony stimulating factor support for advanced malignancies of the chest.

Vokes EE, Haraf DJ, Drinkard LC, Hoffman PC, Ferguson MK, Vogelzang NJ, Watson S, Lane NJ, Golomb HM.

Cancer Chemother Pharmacol. 1995;35(4):304-12.

PMID:
7530173
11.

Phase II study of N-phosphonacetyl-L-aspartate, recombinant interferon-alpha, and fluorouracil infusion in advanced squamous cell carcinoma of the head and neck.

Langer CJ, Schaebler D, Sauter E, DeMaria D, Johnson C, Reilly DM, Clark J, Leighton J, Aks C, Litwin S, Ridge JA.

Head Neck. 1998 Aug;20(5):385-91.

PMID:
9663665
12.

Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.

Hejna M, Kornek GV, Schratter-Sehn AU, Zach M, Schoder M, Raderer M, Rosen H, Schiessel R, Scheithauer W.

Cancer. 1996 Oct 15;78(8):1646-50.

PMID:
8859175
13.
14.

Phase II trial of oxaliplatin, leucovorin and fluorouracil in patients with advanced carcinoma of the esophagus.

Mauer AM, Kraut EH, Krauss SA, Ansari RH, Kasza K, Szeto L, Vokes EE.

Ann Oncol. 2005 Aug;16(8):1320-5. Epub 2005 May 26.

PMID:
15919687
18.

A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma.

Lee J, Im YH, Cho EY, Hong YS, Lee HR, Kim HS, Kim MJ, Kim K, Kang WK, Park K, Shim YM.

Cancer Chemother Pharmacol. 2008 Jun;62(1):77-84. Epub 2007 Aug 31.

PMID:
17762932
19.

Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer.

Taïeb J, Artru P, Baujat B, Mabro M, Carola E, Maindrault F, Tournigand C, Krulik M, Louvet C, de Gramont A.

Eur J Cancer. 2002 Mar;38(5):661-6.

PMID:
11916548
20.

Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.

Ajani JA, Ilson DH, Kelsen DP.

Semin Oncol. 1996 Oct;23(5 Suppl 12):55-8.

PMID:
8941411

Supplemental Content

Support Center